CMS has helped Global Biomet obtain a license for a photovoltaic plant in its portfolio – the 100-megawatt AC capacity Aratiden project – before the Bulgarian State Energy and Water Regulatory Commission.
According to CMS, “the project will start commercial operation in the first quarter of 2024, with an investment cost of EUR 70 million. It will add 5% of installed capacity to Bulgaria’s currently operational 2 gigawatts of solar capacity.”
Back in 2019, CMS successfully represented Global Biomet in proceedings against the Ministry of Finance of the Republic of Bulgaria in a dispute related to the country's feed-in tariff (as reported by CEE Legal Matters on August 19, 2021) and, in 2020, helped the company settle a multi-million euro renewable energy dispute with the Sustainable Energy Development Fund (as reported by CEE Legal Matters on April 23, 2020).
The CMS team included Managing partner Kostadin Sirleshtov and Associates Borislava Piperkova, Elena Yotova-Yordanova, and Diyan Georgiev.